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tion of such growth factors. Of particular interest was the obser-Selective modulation of the secretion of proteinases and their
vation of differences in regulation of proteinases and theirinhibitors by growth factors in cultured differentiated podocytes.
extracellular inhibitors in response to bFGF and TGF-1.Background. Podocyte damage is considered to be an im-
PDGF only slightly increased the secretion of cathepsin L (2.54-portant factor in the development of glomerulosclerosis. Mor-
fold at 20 ng/mL) but exerted no effect on the secretion ofphological studies on experimental models of progressive glo-
cystatin C, MMPs, and TIMP-2 from differentiated podocytes.merular disease have identified the detachment of podocytes
Conclusion. These results indicate, to our knowledge for thefrom the glomerular basement membrane (GBM) as a critical
first time, that in differentiated podocytes, both cathepsin L andstep in the development and progression of glomerulosclerosis.
its inhibitor are independently regulated by different growthDegradation of the GBM by proteinases also might be a poten-
factors. It appears that increases in proteolytic activities maytial mechanism of the detachment because the process impairs
the connection between podocytes and the GBM. The present induce degradation of the glomerular basement membrane
study examined the effects of basic fibroblast growth factor (GBM), which plays an important role in the progression of
(bFGF), transforming growth factor-1 (TGF-1) and platelet- glomerulosclerosis.
derived growth factor (PDGF) on the secretion of proteinases
[cathepsin L and matrix metalloproteinases (MMPs)] and their
inhibitors [cystatin C and tissue inhibitor of metalloprotein-
Podocytes cover the outer aspect of the glomerularase-2 (TIMP-2)] from differentiated podocytes in culture.
basement membrane (GBM) and play a central role asMethods. Expression of mRNAs for receptors of growth
factors (bFGF, PDGF, TGF-1), the proteinases and their in- a filtration barrier [1, 2]. Podocyte damage is considered
hibitors in differentiated podocytes were shown by RT-PCR. to be an important factor in the development of glomeru-
The secretion of cathepsin L, cystatin C and TIMP-2 from dif-
losclerosis in animal models [3–7] and several humanferentiated podocytes were shown by immunoblot analysis.
glomerular diseases [8–10]. Morphological studies on ex-The activities of MMPs-2 and -9 from differentiated podocytes
were shown by gelatin zymography. perimental models of progressive glomerular disease
Results. Expression of mRNAs for receptors of the growth have identified the detachment of podocytes from the
factors, the proteinases and their inhibitors were confirmed. GBM as a critical step in the development and progres-bFGF increased the secretion of cathepsin L (5.04-fold at 20
sion of glomerulosclerosis [1]. This detachment can beng/mL), but did not alter the secretion of its extracellular inhibi-
induced by various pathological processes, such as directtor, cystatin C. In contrast, TGF-1 increased the activities of
MMPs-2 and -9 (3.23-fold at 10 ng/mL and 25.3-fold at 10 podocyte injury, impairment of the podocyte-GBM con-
ng/mL, respectively) from differentiated podocytes, but did not nection, or GBM damage. Several molecular mecha-
enhance the secretion of its inhibitor, TIMP-2. In addition,
nisms for the detachment have been proposed, includingbFGF enhanced the secretion of TIMP-2 (2.75-fold at 20
reorganization of the actin cytoskeleton in podocytesng/mL) and TGF-1 enhanced the secretion of cystatin C (2.32-
fold at 20 ng/mL). These results demonstrate the imbalance of [11], apoptosis of podocytes [12] and oxidation of the
the secretion of proteinases and their inhibitors after incuba- GBM [13]. Degradation of the GBM by proteinases also
may be a potential mechanism of the detachment be-
cause the process impairs the connection between podo-Key words: cathepsin L, cystatin C, matrix metalloproteinase, TIMP-2,
glomerulosclerosis, progressive renal disease. cytes and the GBM.
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uli contain several proteinases, most notably metallopro- cytes between passages 20 and 30 were used in all experi-
ments. Viability and counts of these cells were evaluatedteinases (MMPs) and a cysteine proteinase, cathepsin L
[14, 16]. MMPs are proteinases specific for the basement by trypan blue exclusion after treatment with growth
factors (trypan blue exclusion test).membrane proteins. Several in vitro studies have demon-
strated that glomerular mesangial and epithelial cells
RNA preparation and RT-PCRsecrete MMPs [18–22]. Cathepsin L is one of the lyso-
somal cysteine proteinases with a relatively broad sub- To prepare for reverse transcription-polymerase chain
reaction (RT-PCR), podocytes were incubated at 1.2 strate specificity [23] and differs from other cysteine pro-
teinases in two ways: (1) procathepsin L, a proform, is 106 on type I collagen coated 10 cm dishes under permis-
sive conditions. After differentiation, podocytes wereabundantly secreted into the extracellular space, and
(2) procathepsin L itself and its processed form, cathep- cultured in FCS free medium containing 0.1% bovine
serum albumin (BSA) for 24 hours. Total RNA of podo-sin L, effectively digest the extracellular matrix proteins
[23, 24]. In vitro studies using isolated glomeruli have cytes was extracted with an RNeasy Mini Kit (QIAGEN,
Hilden, Germany) for RNA preparation. One micro-demonstrated that endogenous cathepsin L degrades the
GBM [16]. Recently, an immunohistochemical study gram of total RNA was reverse-transcribed using oligo
(dT) 12-18 primers (Life Technologies, Rockville, MD,showed that cathepsin L is selectively localized in podo-
cytes (abstract; Shirato et al, J Am Soc Nephrol 9:509, USA) and reverse transcriptase, Superscript II (Life
Technologies). The single-strand cDNA product was de-1998). The secretion of these proteinases is stimulated
by growth factors, some of which are known to contribute natured and amplified in the GeneAmp PCR System
9600 (Perkin-Elmer, Norwalk, CT, USA). Differentiatedto the development and progression of glomerulosclero-
sis [25–27]. Thus, it is hypothesized that growth factors podocyte cDNA was amplified using various primers
specific only for the cDNA sequences of the mouse fi-may induce the secretion of proteinases from podocytes.
The activity of proteinases secreted from podocytes is broblast growth factor (FGF) receptor-1, mouse platelet-
derived growth factor (PDGF) receptor- polypeptide,relevant to podocyte detachment, and thereby contrib-
utes to the development and progression of glomerulo- mouse transforming growth factor (TGF)--type 1 re-
ceptor, mouse cathepsin L, mouse cystatin C, mouse met-sclerosis since it causes extracellular degradation of the
GBM proteins. alloproteinases-2 and -9 (MMP-2 and MMP-9), or mouse
tissue inhibitor of metalloproteinase-2 (TIMP-2; Ta-In the present study, we investigated the effects of
growth factors on the secretion of proteinases and their ble 1). The amplified products were confirmed by se-
quencing.inhibitors from cultured differentiated podocytes, which
were recently established by Mundel et al [28]. It appears
Preparation of podocyte conditioned media samplesthat the growth factors enhanced the secretion of pro-
teinases to different degrees but not their inhibitors. Podocytes were incubated at 6  105 on type I colla-
gen coated 6 cm dishes under permissive conditions.
After differentiation, the culture was continued with
METHODS
FCS-free medium containing 0.1% BSA for 24 hours.
Cell culture of podocytes To study the influence of growth factors on cathepsin L,
cystatin C, MMPs and TIMP-2 production, treatmentConditionally immortalized mouse podocyte clone
was kindly provided by Dr. Peter Mundel (Albert Ein- with each growth factor [recombinant human basic-
fibroblast growth factor (bFGF), recombinant humanstein College of Medicine, Bronx, NY, USA). The prepa-
ration and characterization of these cells has been de- PDGF-B/B, and recombinant human TGF-1 (Roche
Diagnostics GmbH, Mannheim, Germany)] was carriedscribed in detail elsewhere [28]. Podocytes were maintained
in RPMI 1640 medium (Iwaki Glass, Tokyo, Japan) sup- out at different concentrations (bFGF at 1, 5, 10, and 20
ng/mL; PDGF at 1, 5, 10, and 20 ng/mL; or TGF-1 atplemented with 10% heat-inactivated fetal calf serum
(FCS; Gibco BRL, Gaithersburg, MD, USA), 100 U/mL 0.1, 1, and 10 ng/mL) up to 24 hours. The conditioned
media were collected and centrifuged to remove anyof penicillin G and 100 g/mL of streptomycin in a hu-
midified atmosphere with 5% CO2. To propagate podo- non-adherent cells. The supernatants were concentrated
50-fold for immunoblot and 10-fold for gelatin zymogra-cytes, the culture medium was supplemented with 10
U/mL recombinant mouse -interferon (Pepro Tech EC phy by ultrafiltration using a membrane filter (Centricon
YM-10; Millipore, MA, USA). These samples were storedLtd, London, UK) to enhance the expression of T-anti-
gen, and the cells were cultured at 33C (permissive at 80C.
conditions). Podocytes were cultured on type I collagen
Immunoblot analysescoated dishes (Iwaki Glass) at 37C (non-permissive con-
ditions) to induce differentiation without -interferon. Sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and immunoblot analyses wereIt took at least five days to induce differentiation. Podo-
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Fig. 1. RT-PCR analyses of the receptors for growth factors in differen-
tiated podocytes. One microgram of total RNA from differentiated
podocytes was reverse-transcribed to cDNA with oligo (dT) 12-18
primer. PCR amplification of the cDNA with the specific primer sets Fig. 2. RT-PCR analyses of the proteinases and their inhibitors in
(Table 1) for mouse FGF receptor-1 (lane 1, 623 bp), PDGF receptor- differentiated podocytes. One microgram of total RNA from differenti-
polypeptide (lane 2, 637 bp) and TGF- type 1 receptor (lane 3, 766 ated podocytes was reverse-transcribed to cDNA with oligo (dT) 12-18
bp) was performed. The sequences of the products were confirmed by primer. cDNA for mouse cathepsin L (lane 1, 424 bp), mouse cystatin C
an autosequencer. The arrows on the left side indicate the DNA length (lane 2, 456 bp), mouse MMP-2 (lane 3, 760 bp), mouse MMP-9 (lane 4,
markers (800 bp and 600 bp). 414 bp) and TIMP-2 (lane 5, 309 bp) were amplified by PCR with
specific primer sets (Table 1). DNA length markers (600 bp and 400
bp) are indicated with arrows on the left side of the panel.
carried out according to standard protocols [29, 30] and
visualized using enhanced chemiluminescence (ECL)
USA) and observed under a fluorescence microscope.immunoblot detection kits (Amersham Pharmacia Bio-
All processes were performed at room temperature.tech, Little Chalfont, Buckinghamshire, UK) and Konica
immunostaining kits (Konica, Tokyo, Japan). The first Gelatin zymography
antibodies used in this study were as follows: rabbit anti-
Enzyme activity in the conditioned media obtainedmouse cathepsin L antibody (2.5 g/mL) [31], rabbit
from differentiated podocytes was monitored by gelatinanti-human cystatin C antibody (2 g/mL) (Upstate Bio-
zymography. For gelatin zymography, protein of the con-
technology, Lake Placid, NY, USA) and mouse anti-
ditioned medium with 4  sample buffer [125 mmol/L
human TIMP–2 antibody (1:200) (Fuji-Chemical Co.
Tris-HCl at pH 6.8, 4% SDS, 4 mmol/L ethylenediamine-
Ltd., Toyama, Japan). The intensities of proteins on the tetraacetic acid (EDTA), 40% glycerol, 0.003% bromo-
membranes were measured in the Master Scan (Scana- phenol blue (BPB)], separated in 7.5% polyacrylamide
lytics, Billerica, MA, USA) according to the manufac- SDS gel containing 0.8 mg/mL gelatin, was used. After
turer’s protocol. electrophoresis, the gels were washed and then incubated
with 50 mmol/L Tris-HCl buffer at pH 7.5 and 10 mmol/LImmunofluorescence microscopy
CaCl2 at 37C for 18 hours. Enzyme activities were visual-
After differentiation, cells were grown on collagen ized with Coomassie brilliant blue R-250. Human MMPs-2
type I-coated glass cover slips for immunocytochemistry. and -9 (Sigma Chemical Co., St. Louis, MO, USA) were
The culture was continued with FCS-free medium con- loaded with samples to confirm the mobility of MMPs
taining 0.1% BSA for 24 hours. To study the influence of in the gels. The intensities of the bands on the gels were
growth factors on cathepsin L, treatment with each measured in the Master Scan.
growth factor was carried out at a concentration of 10
ng/mL bFGF or 10 ng/mL PDGF for up to 12 hours. Statistical analysis
The cells were washed with ice-cold phosphate-buffered All values were expressed as means  SE. Statistical
saline (PBS) twice and then fixed in ice-cold methanol significance (defined as P  0.05) was evaluated using
at 20C for five minutes. After fixation, the cells were one-way analysis of variance (ANOVA) followed by the
permeabilized with ice-cold acetone at 20C for five Bonferroni/Dunn t test.
minutes, quenched with 50 mmol/L NH4Cl in PBS for
10 minutes, transferred to blocking solution (2% FCS,
RESULTS2% BSA and 0.2% fish gelatin in PBS), and incubated
Expression of mRNAs of receptors of growthfor 30 minutes. The cells were incubated with anti-
factors, proteinases and their inhibitors incathepsin L antibody (2.5 g/mL) diluted in blocking
differentiated podocytessolution for one hour. After washing the cells three times
with PBS, they were incubated with the second antibod- It has been reported that FGF receptor-1 [32], TGF-
ies conjugated with FITC diluted in blocking solution receptor type 1 [33] and PDGF receptor- polypeptide
for one hour and then washed five times with PBS. Fi- [34] are expressed in glomeruli. Each receptor has been
nally, they were mounted with PermaFluor Aqueous suggested to play an important role under normal and
pathological conditions. Before examination of the ef-Mounting Medium (Thermo Shandon, Pittsburgh, PA,
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Table 1. PCR primer sequences of receptors of growth factor, proteinases and their inhibitors
Fragment Annealing PCR
Gene Primer sequencea size temperature cycle
FGF receptor-1 5	 Primer 
 5	-ATGAAGAGCGGCACCAAGAA-3	 623 bp 59C 35
3	 Primer 
 5	-TGATAGGCACAGGATACCAG-3	
PDGF receptor- polypeptide 5	 Primer 
 5	-CTGATCTTTCTAGGGGTCAG-3	 637 bp 54C 35
3	 Primer 
 5	-CTTCCGGTGTCTAAATGTGG-3	
TGF- type 1 receptor 5	 Primer 
 5	-CTGGGTGTTTAGGAGGCTGG-3	 766 bp 59C 35
3	 Primer 
 5	-CAGCCTTGCCTCAGTGGTTC-3	
Cathepsin L 5	 Primer 
 5	-TCTCACGCTCAAGGCAATCAGG-3	 424 bp 61C 25
3	 Primer 
 5	-AGCCTTCCATACCCCATTCACTTC-3	
Cystatin C 5	 Primer 
 5	-AGCGAGTACAACAAGGGCAG-3	 457 bp 57C 30
3	 Primer 
 5	-CAAGAAGAGTGAAGCCAGGG-3	
MMP-2 5	 Primer 
 5	-CCTGATGTCCAGCAAGTAGATGC-3	 760 bp 55C 30
3	 Primer 
 5	-TTAAGGTGGTGCAGGTATCTGG-3	
MMP-9 5	 Primer 
 5	-TTCTCTGGACGTCAAATGTGG-3	 414 bp 55C 35
3	 Primer 
 5	-CAAAGAAGGAGCCCTAGTTCAAGG-3	
TIMP-2 5	 Primer 
 5	-CTCGCTGGACGTTGGAGGAA-3	 309 bp 57C 35
3	 Primer 
 5	-CACGCGCAAGAACCATCACT-3	
a PCR product verified by sequencing
fects of bFGF, PDGF and TGF-1 on differentiated po- with 20 ng/mL bFGF and 20 ng/mL PDGF (5.04  1.09-
fold and 2.54  0.42-fold of control; P  0.05). We alsodocytes, the presence of receptors of the growth factors
was investigated at mRNA levels in the cells. We con- confirmed that bFGF stimulated secretion more effec-
tively than PDGF on the same membrane (Fig. 3D). Infirmed that cultured differentiated podocytes express
mRNAs of such receptors (Fig. 1). The results suggested contrast to these growth factors, TGF-1 did not affect
the secretion of procathepsin L (Fig. 3C).that each growth factor binds to the receptors for each
growth factor and the signal modulates the secretion Treatment with bFGF and PDGF should stimulate
the expression of cathepsin L in differentiated podocytes.of proteinases and their inhibitors from differentiated
podocytes. The expression of mRNAs of cathepsin L, The expression of cathepsin L in differentiated podo-
cytes was examined immunocytochemically after treat-MMPs-2 and -9 and their inhibitors (cystatin C and
TIMP-2) also was confirmed (Fig. 2) using primer sets ment with growth factors (Fig. 4). Treatment with bFGF
and PDGF for 12 hours induced the expression of ca-for the individual mouse proteins (Table 1).
thepsin L in differentiated podocytes (Fig. 4 A, B). We
Effects of growth factors on the secretion of also confirmed that bFGF stimulated the expression of
cathepsin L and its extracellular inhibitor, cathepsin L more effectively than PDGF. In contrast
cystatin C, from differentiated podocytes to these growth factors, TGF-1 did not stimulate the
expression of cathepsin L in differentiated podocytesThe murine podocyte cell line used in this study ex-
presses various podocyte markers including nephrin and (data not shown).
To evaluate the proteolytic effect of secreted pro-CD2AP [35], VEGF [36], podocalyxin, glepp1 and po-
docin (Dr. Peter Mundel, personal communication) as cathepsin L, we investigated the secretion of its extracel-
lular inhibitor cystatin C. Immunoblot analyses of thewell as synaptopodin [28]. Only one marker, synapto-
podin, was confirmed in this study. These results indicate medium demonstrated the constitutive secretion of cys-
tatin C (13 kD; representative results shown in Fig. 5)that the cell line we used was definitely identified as
podocytes. from unstimulated cells. In contrast to the increased se-
cretion of procathepsin L after stimulation with bFGFThe trypan blue exclusion test showed that the number
of cells after treatment with the growth factors was com- and PDGF, these two growth factors did not affect the
secretion of cystatin C (Fig. 5 A, B). However, TGF-1parable to those in serum-free medium. Using anti-
mouse cathepsin L antibody that recognizes both the increased the secretion of cystatin C in a dose-dependent
manner (Fig. 5C). The secretion of cystatin C was sig-mature and proform of cathepsin L, the cells were found
to secrete only procathepsin L (39 kD; representative nificantly increased by treatment with 10 ng/mL TGF-1
(2.32  0.3-fold of control; P  0.05).results shown in Fig. 3) under all conditions. Mature
cathepsin L was not detectable in the culture medium.
Effects of growth factors on the secretion of MMPs-2Unstimulated podocytes constitutively secreted small
and -9, and their inhibitor, TIMP-2, fromamounts of procathepsin L. Treatment with bFGF and
differentiated podocytesPDGF for 24 hours induced secretion of procathepsin L
in a dose-dependent manner (Fig. 3 A, B). The secretion Two types of gelatinolytic proteinases of 72 kD and
92 kD, which corresponded to precursor forms of MMPs-2of procathepsin L significantly increased on treatment
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and -9, respectively, were detected in the medium (Fig. 6).
Stimulation of the cells with bFGF and PDGF did not
affect the secretion of the enzymes (representative re-
sults shown in Fig. 6 A, B). Although the bands corre-
sponding to MMP-9 in Figure 6 panels A and B appeared
to increase after treatment with 10 ng/mL bFGF and 5
ng/mL PDGF, the data were not statistically significant.
In contrast, TGF-1 increased the secretion of MMPs-2
and -9 in a dose-dependent manner (Fig. 6C). The gela-
tinolytic activities of MMP-2 and MMP-9 significantly
increased on treatment with 10 ng/mL TGF-1 (3.23 
0.78-fold and 25.25  12.54-fold of control; P  0.05,
Fig. 6C).
The cells under unstimulated conditions constitutively
secreted small amounts of TIMP-2 (20.5 kD, representa-
tive results shown in Fig. 7). bFGF increased the secre-
tion of TIMP-2 in a dose-dependent manner (Fig. 7A),
but had no effect on the secretion of MMPs-2 and -9
in the medium. The secretion of TIMP-2 significantly
increased on treatment with 20 ng/mL bFGF (2.75 
0.68-fold of control; P  0.05). PDGF had no effect on
the secretion of TIMP-2 (Fig. 7B), which was compatible
with its lack of any effect on the secretion of MMPs in the
medium. TGF-1 did not affect the secretion of TIMP-2
(Fig. 7C).
DISCUSSION
The results of this study revealed the secretion of
proteinases and their inhibitors from differentiated po-
docytes showed differences in regulation by different
growth factors. The presence of bFGF increased the
secretion of cathepsin L, but did not alter the secretion
of their extracellular inhibitor, cystatin C. In contrast,
TGF-1 increased the activities of MMPs-2 and -9 from
differentiated podocytes, but did not alter the secretion
of their inhibitor, TIMP-2. The imbalance of the reactivi-
ties of proteinases and their inhibitors suggests that in-
creasing proteolytic activities may induce degradation of
the GBM, resulting in increasing glomerular permeabil-
ity as well as detachment of podocytes from the GBM.
This activity plays an important role in the progression
of glomerulosclerosis.
Fig. 3. Immunoblot analyses of cathepsin L in medium of differentiated
podocytes. Differentiated podocytes were cultured in medium with
0.1% BSA for 24 hours and further cultured in the presence of growth growth factors are shown at the bottom of the panels. (D) Results of
factors for 24 hours: (A) basic fibroblast growth factor (bFGF), (B) immunoblot with anti-mouse cathepsin L of the medium of differenti-
platelet-derived growth factor (PDGF), (C ) transforming growth ated podocytes treated with PDGF (20 ng/mL) and bFGF (20 ng/mL)
factor- (TGF-1). The trypan blue exclusion test showed that the respectively for 24 hours. Arrows on the left sides of the panels indicate
numbers and viabilities of cells after treatment with growth factors did procathepsin L. Arrows on the right sides of the panels indicate the
not differ from those before treatment. The 50-fold concentrated culture molecular weight (39 kD) of the band. Graphs under the panels indicate
media were fractionated in SDS-gels and transferred onto polyvinyli- data in arbitrary units of the density of each band per that of the control
dene difluoride (PVDF) membranes. Procathepsin L on the membrane band on the same membranes. The columns represent the mean  SE
was detected with anti-mouse cathepsin L antibody. The antibodies of each value from different experiments: bFGF, N 
 5; PDGF, N 

were bound with horseradish peroxidase conjugated anti-rabbit IgG 3; TGF-1, N 
 4. Asterisks show that the difference of the arbitrary
antibody and visualized by the ECL system. The concentrations of units to the control is significant at 95% confidence.
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Fig. 4. Expression of cathepsin L in differentiated podocytes by immunocytochemistry after treatment with growth factors. After differentiation,
cells were grown on collagen type I-coated glass. The culture was continued with FCS-free medium containing 0.1% BSA for 24 hours. Treatment
with each growth factor was carried out at a concentration up to 12 hours: (A) bFGF at 10 ng/mL; (B) PDGF at 10 ng/mL; (C ) control. After
fixation and permeabilization, the cells were incubated with anti-cathepsin L antibody for one hour. After washing with PBS, they were incubated
with the second antibodies for one hour. Finally, they were observed under a fluorescence laser scanning microscope. All processes were conducted
at room temperature. Bar, 25 m.
Several studies have demonstrated that bFGF can in- abundant extracellular inhibitor of cysteine proteinases.
An important role of the imbalance of cysteine protein-duce podocyte damage associated with increased glomer-
ular permeability and glomerulosclerosis [25, 37, 38]. ases and cystatin C reactivities has been reported re-
cently in atherosclerotic and aneurysmal aortic lesionsLong-term treatment of rats with bFGF demonstrated
the development and progression of glomerulosclerosis, where excess breakdown of elastic laminae by cysteine
proteinases contributes to the development of such le-which was based on podocyte damage including podo-
cyte detachment from the GBM [25]. Administration of sions [41]. Thus, the imbalance between cathepsin L and
cystatin C in the extracellular space strongly suggestedsmall amounts of bFGF to rats with passive Heymann
nephritis markedly enhanced the development of glomer- increased proteolytic activity of cathepsin L, which re-
sults in degradation of the GBM.ulosclerosis, which depends on podocyte damage [37].
In addition, treatment with bFGF neutralizing antibody One argument against the earlier-mentioned mecha-
nism is that an acidified microenvironment is necessarydecreased podocyte damage as well as proteinuria in rats
with puromycin aminonucleoside nephrosis [38]. How- for cathepsin L to act effectively on the glomerular capil-
lary wall, which is assumed to have a neutral pH underever, it is still unclear how bFGF induces podocyte dam-
age. The present study showed that bFGF increased the physiological conditions. However, the extracellular mi-
croenvironment at acidic pH has been identified in vari-secretion of procathepsin L, the proform of cathepsin L,
from differentiated podocytes. Secreted procathepsin L ous pathological conditions, such as in cardiac ischemia
[42], rheumatoid arthritis [43] and various tumors [44, 45].itself has been reported to degrade extracellular matrix
proteins such as laminin and fibronectin [39]. Further- It also has been reported that cells such as macrophages
and osteoclasts can generate a local acidified environ-more, it was demonstrated that secreted procathepsin L
is converted autocatalytically to mature cathepsin L in ment [46, 47], which enables cysteine proteinases to func-
tion outside the cells. In rat glomerular epithelial cellsthe presence of the cell surface glycosaminoglycans, in-
cluding heparan sulfate proteoglycans, at acidic pH [39]. (GECs), it has recently been indicated that pH of the
medium in the basolateral compartment is lowered dur-The processed cathepsin L degraded extracellular matrix
proteins such as type IV collagen, fibronectin, and lami- ing exposure to interleukin-4 (IL-4) or IL-13 [48]. The mi-
croenvironment in a segment of glomeruli affected bynin [24, 31, 40]. Accordingly, our results in this study
suggested that bFGF induces degradation of the GBM severe glomerular damage including sclerosis is presumed
to be acidic, and this may provide a mechanism for cathep-by increased secretion of procathepsin L from podocytes
and contributes to podocyte detachment from the GBM. sin L to act effectively on the glomerular capillary wall.
Transforming growth factor-1 is well known to con-This hypothesis also is supported by evidence that bFGF
did not increase the secretion of cystatin C, the most tribute to pathophysiological processes in the develop-
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ment and progression of glomerulosclerosis [49, 50]. It
has been reported recently that TGF-1 has effects on
podocytes as well as mesangial cells. Transgenic mice
with elevated levels of circulating TGF-1 developed
progressive glomerulosclerosis [26]. In such mice, podo-
cyte damage and podocyte apoptosis occurred early in
the course of glomerulosclerosis [12]. With regard to the
effect of TGF-1 on the secretion of proteinases, an in
vitro study using human GECs demonstrated that the
growth factor increased the secretion of metalloprotein-
ases, MMPs-2 and -9, but decreased the secretion of their
inhibitor, TIMP-2 [22]. The present study demonstrates
that TGF-1 increased the activity of MMPs-2 and -9 in
culture media using differentiated podocytes. The secre-
tion of TIMP-2 from podocytes was not altered by stimu-
lation of TGF-1. In any case, these data indicate that
TGF-1 might increase degradation of the GBM, a key
step in the development and progression of glomerulo-
sclerosis.
It has been suggested that cathepsin L and MMPs not
only digest the ECM, but also convert pro-enzyme to
the active form or generate active peptide. Therefore,
they may be associated with pathological lesions. Re-
cently, it was reported that cathepsin L secreted from
murine hemangioendothelioma cells generated endo-
statin, an inhibitor of angiogenesis, from collagen XVIII,
the core protein of heparan sulfate proteoglycan [51].
MMP-2 secreted from fibrogenic cells also participates
in the activation of lysyl oxidase, which initiates cross-
link formation of collagen and elastin in the extracellular
matrix [52]. In glomeruli, other unknown active peptides
as well as endostatin or lysyl oxidase, which is generated
by cathepsin L or MMPs secreted from podocytes, may
also contribute to the progression of glomerulosclerosis.
Platelet-derived growth factor induces selective mes-
angial cell proliferation and contributes to many progres-
sive glomerular diseases [27, 53, 54]. However, it has not
been reported that PDGF is related to podocyte damage.
In this study, PDGF only slightly increased the secretion
of cathepsin L but exerted no effect on the secretion
of cystatin C, MMPs, and TIMP-2 from differentiated
podocytes despite the presence of its receptor on the
podocytes. These findings suggest that PDGF is partially
Fig. 5. Immunoblot analyses of cystatin C in the medium of differenti- involved in the pathological mechanisms of podocyte
ated podocytes. The samples were prepared as described in the legend damage induced by the imbalance of proteinases andto Figure 3. Cystatin C on the membranes was detected with anti-mouse
their inhibitor reactivities. Although TIMP-1, which bindscystatin C antibody. Arrows on the left side of the panels indicate the
specific bands of cystatin C. Arrows on the right sides of the panels selectively to MMP-9, should be investigated in each
indicate the molecular weight (13 kD) of the band. Graphs under the case, we could not find an appropriate antibody againstpanels show densitometric analyses of the bands, which were expressed
mouse TIMP-1. However, the activity of MMP-9 was sig-as relative intensities of the density of each band per that of the control
on the same membranes. The data represent the mean  SE of each nificantly lower than that of MMP-2. It was suggested
value from different experiments: bFGF, N
 4; PDGF, N
 3; TGF-1, that the activity of MMP-9 from differentiated podo-N 
 4. Asterisks show that the difference of the arbitrary units to the
cytes, which participates in the degradation of the GBM,control is significant at 95% confidence.
was lower than that of MMP-2.
In summary, it appears that the secretion of protein-
ases and their inhibitors from differentiated podocytes
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Fig. 6. Gelatin zymographies of the medium
for differentiated podocytes. The differenti-
ated podocytes were cultured in RPMI 1640
and 0.1% BSA for 24 hours and then treated
with the growth factors (A, bFGF; B, PDGF;
C, TGF-1) at the concentrations at the bot-
tom of the panels for 24 hours. The tenfold
concentrated medium was electrophoresed in
7.5% SDS-gel containing gelatin (0.8 mg/mL).
The gels were incubated in 50 mmol/L Tris-
HCl (pH 7.5) and 10 mmol/L CaCl2 at 37C
for 15 hours and then stained with Coomassie
brilliant blue R-250. Each 50 ng of human
matrix metalloproteinases (MMPs)-2 and -9
was loaded to confirm the mobility of MMPs
(C) in the gel. Graphs under the panels indi-
cate densitometric analysis of the bands on
MMP-2 and MMP-9, which were expressed as
arbitrary units. Data represent the mean 
SE of each value from different experiments
(bFGF, N 
 5; PDGF, N 
 3; TGF-1, N 

5). Asterisks show that the difference of the
arbitrary units to the control is significant at
95% confidence.
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